Skip to main content
Erschienen in:
Buchtitelbild

2013 | OriginalPaper | Buchkapitel

3. Intracoronary Stents: Medical Devices at the Interface of Biology and Electrochemistry

verfasst von : Michael B. Boffa, Marlys L. Koschinsky

Erschienen in: Applications of Electrochemistry in Medicine

Verlag: Springer US

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config
loading …

Abstract

Despite the many significant advances in the diagnosis and treatment of cardiovascular diseases that have occurred over the past three decades, these disorders remain a primary cause of both morbidity and mortality worldwide. In fact, ischaemic heart disease (essentially, heart attacks and their sequelae) are the single leading cause of death, accounting for almost 13 % of deaths worldwide [1]. Since their introduction nearly 20 years ago, intracoronary stents have become an indispensable tool in the arsenal of interventional cardiologists for the prevention and treatment of ischaemic heart disease. These devices, generally consisting of a tubular metal scaffold with some coating to ensure biocompatibility and reduce complications (Fig. 3.1), serve to restore patency to occluded arteries and to stave off their reocclusion. What is fascinating about stents is that they stand at the interface of the fields of engineering, chemistry (particularly materials chemistry and electrochemistry), biology, and medicine. In this chapter, we will review some of the disease biology of atherosclerosis—the pathological process that ultimately gives rise to ischaemic heart disease—before reviewing the history of stent development and some of the common features of these devices. The heart of this chapter, however, will focus on the ongoing research in the area of electrochemistry that is aimed at optimizing the properties of intracoronary stents.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 340 Zeitschriften

aus folgenden Fachgebieten:

  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Versicherung + Risiko




Jetzt Wissensvorsprung sichern!

Literatur
2.
Zurück zum Zitat Ross R. Atherosclerosis—an inflammatory disease. N Engl J Med. 1999; 340:115–26.CrossRef Ross R. Atherosclerosis—an inflammatory disease. N Engl J Med. 1999; 340:115–26.CrossRef
3.
Zurück zum Zitat Cheng C, Tempel D, van Haperen R, van der Baan A, Grosveld F, Daemen MJ, et al. Atherosclerotic lesion size and vulnerability are determined by patterns of fluid shear stress. Circulation. 2006;113:2744–53.CrossRef Cheng C, Tempel D, van Haperen R, van der Baan A, Grosveld F, Daemen MJ, et al. Atherosclerotic lesion size and vulnerability are determined by patterns of fluid shear stress. Circulation. 2006;113:2744–53.CrossRef
4.
Zurück zum Zitat Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation. 2004;109(23 Suppl 1):III27–32. Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation. 2004;109(23 Suppl 1):III27–32.
5.
Zurück zum Zitat Le Brocq M, Leslie SJ, Milliken P, Megson IL. Endothelial dysfunction: from molecular mechanisms to measurement, clinical implications, and therapeutic opportunities. Antioxid Redox Signal. 2008;10:1631–74.CrossRef Le Brocq M, Leslie SJ, Milliken P, Megson IL. Endothelial dysfunction: from molecular mechanisms to measurement, clinical implications, and therapeutic opportunities. Antioxid Redox Signal. 2008;10:1631–74.CrossRef
6.
Zurück zum Zitat Higashi Y, Noma K, Yoshizumi M, Kihara Y. Endothelial function and oxidative stress in cardiovascular diseases. Circ J. 2009;73:411–8.CrossRef Higashi Y, Noma K, Yoshizumi M, Kihara Y. Endothelial function and oxidative stress in cardiovascular diseases. Circ J. 2009;73:411–8.CrossRef
7.
Zurück zum Zitat Allahverdian S, Pannu PS, Francis GA. Contribution of monocyte-derived macrophages and smooth muscle cells to arterial foam cell formation. Cardiovasc Res. 2012;95(2):165–72.CrossRef Allahverdian S, Pannu PS, Francis GA. Contribution of monocyte-derived macrophages and smooth muscle cells to arterial foam cell formation. Cardiovasc Res. 2012;95(2):165–72.CrossRef
8.
Zurück zum Zitat Mizuno Y, Jacob RF, Mason RP. Inflammation and the development of atherosclerosis. J Atheroscler Thromb. 2011;18:351–8.CrossRef Mizuno Y, Jacob RF, Mason RP. Inflammation and the development of ­atherosclerosis. J Atheroscler Thromb. 2011;18:351–8.CrossRef
9.
Zurück zum Zitat Finn AV, Nakano M, Narula J, Kolodgie FD, Virmani R. Concept of vulnerable/unstable plaque. Arterioscler Thromb Vasc Biol. 2010;30:1282–92.CrossRef Finn AV, Nakano M, Narula J, Kolodgie FD, Virmani R. Concept of vulnerable/unstable plaque. Arterioscler Thromb Vasc Biol. 2010;30:1282–92.CrossRef
10.
Zurück zum Zitat Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation. 1995; 92:657–71.CrossRef Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation. 1995; 92:657–71.CrossRef
11.
Zurück zum Zitat Michaels AD, Chatterjee K. Angioplasty versus bypass surgery for coronary artery disease. Circulation. 2002;106:e187–90.CrossRef Michaels AD, Chatterjee K. Angioplasty versus bypass surgery for coronary artery disease. Circulation. 2002;106:e187–90.CrossRef
12.
Zurück zum Zitat King SB, Schlumpf M. Ten-year completed follow-up of percutaneous transluminal coronary angioplasty: the early Zurich experience. J Am Coll Cardiol. 1993;22:353–60.CrossRef King SB, Schlumpf M. Ten-year completed follow-up of percutaneous transluminal coronary angioplasty: the early Zurich experience. J Am Coll Cardiol. 1993;22:353–60.CrossRef
13.
Zurück zum Zitat Ruygrok PN, de Jaegere PT, van Domburg RT, van den Brand MJ, Serruys PW, de Feyter PJ. Clinical outcome 10 years after attempted percutaneous transluminal coronary angioplasty in 856 patients. J Am Coll Cardiol. 1996; 27:1669–77.CrossRef Ruygrok PN, de Jaegere PT, van Domburg RT, van den Brand MJ, Serruys PW, de Feyter PJ. Clinical outcome 10 years after attempted percutaneous transluminal coronary angioplasty in 856 patients. J Am Coll Cardiol. 1996; 27:1669–77.CrossRef
14.
Zurück zum Zitat Serruys PW, Jaegere PD, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med. 1994; 331:489–95.CrossRef Serruys PW, Jaegere PD, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med. 1994; 331:489–95.CrossRef
15.
Zurück zum Zitat Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med. 1994;331: 496–501.CrossRef Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, et al. A ­randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med. 1994;331: 496–501.CrossRef
16.
Zurück zum Zitat Serruys PW, Kutryk MJ, Ong AT. Coronary-artery stents. N Engl J Med. 2006;354:483–95.CrossRef Serruys PW, Kutryk MJ, Ong AT. Coronary-artery stents. N Engl J Med. 2006;354:483–95.CrossRef
17.
Zurück zum Zitat Sigwart U, Puel J, Mirkovitch V, Joffre F, Kappenberger L. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med. 1987;316:701–6.CrossRef Sigwart U, Puel J, Mirkovitch V, Joffre F, Kappenberger L. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med. 1987;316:701–6.CrossRef
18.
Zurück zum Zitat Mani G, Chandrasekar B, Feldman MD, Patel D, Agrawal CM. Interaction of endothelial cells with self-assembled monolayers for potential use in drug-eluting coronary stents. J Biomed Mater Res B Appl Biomater. 2009;90: 789–801. Mani G, Chandrasekar B, Feldman MD, Patel D, Agrawal CM. Interaction of endothelial cells with self-assembled monolayers for potential use in drug-­eluting coronary stents. J Biomed Mater Res B Appl Biomater. 2009;90: 789–801.
19.
Zurück zum Zitat Rothman MT, Davies SW. Intracoronary stents. Br Heart J. 1992;67:425–7.CrossRef Rothman MT, Davies SW. Intracoronary stents. Br Heart J. 1992;67:425–7.CrossRef
20.
Zurück zum Zitat Palmaz JC, Sibbitt RR, Reuter SR, Tio FO, Rice WJ. Expandable intraluminal graft: a preliminary study. Work in progress. Radiology. 1985;156:73–7. Palmaz JC, Sibbitt RR, Reuter SR, Tio FO, Rice WJ. Expandable intraluminal graft: a preliminary study. Work in progress. Radiology. 1985;156:73–7.
21.
Zurück zum Zitat Palmaz JC, Windeler SA, Garcia F, Tio FO, Sibbitt RR, Reuter SR. Atherosclerotic rabbit aortas: expandable intraluminal grafting. Radiology. 1986;160:723–6. Palmaz JC, Windeler SA, Garcia F, Tio FO, Sibbitt RR, Reuter SR. Atherosclerotic rabbit aortas: expandable intraluminal grafting. Radiology. 1986;160:723–6.
22.
Zurück zum Zitat Schatz RA, Baim DS, Leon M, Ellis SG, Goldberg S, Hirshfeld JW, et al. Clinical experience with the Palmaz-Schatz coronary stent. Initial results of a multicenter study. Circulation. 1991;83:148–61.CrossRef Schatz RA, Baim DS, Leon M, Ellis SG, Goldberg S, Hirshfeld JW, et al. Clinical experience with the Palmaz-Schatz coronary stent. Initial results of a multicenter study. Circulation. 1991;83:148–61.CrossRef
23.
Zurück zum Zitat Moussa I, Di Mario C, Reimers B, Akiyama T, Tobis J, Colombo A. Subacute stent thrombosis in the era of intravascular ultrasound-guided coronary stenting without anticoagulation: frequency, predictors and clinical outcome. J Am Coll Cardiol. 1997;29:6–12.CrossRef Moussa I, Di Mario C, Reimers B, Akiyama T, Tobis J, Colombo A. Subacute stent thrombosis in the era of intravascular ultrasound-guided coronary stenting without anticoagulation: frequency, predictors and clinical outcome. J Am Coll Cardiol. 1997;29:6–12.CrossRef
24.
Zurück zum Zitat Topol EJ. Caveats about elective coronary stenting. N Engl J Med. 1994; 331:539–41.CrossRef Topol EJ. Caveats about elective coronary stenting. N Engl J Med. 1994; 331:539–41.CrossRef
25.
Zurück zum Zitat Hoffmann R, Mintz GS, Dussaillant GR. Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study. Circulation. 1996; 94: 1247–54.CrossRef Hoffmann R, Mintz GS, Dussaillant GR. Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study. Circulation. 1996; 94: 1247–54.CrossRef
26.
Zurück zum Zitat Holmes J. State of the art in coronary intervention. Am J Cardiol. 2003; 91:50A–3.CrossRef Holmes J. State of the art in coronary intervention. Am J Cardiol. 2003; 91:50A–3.CrossRef
27.
Zurück zum Zitat Holmes Jr DR, Savage M, LaBlanche JM, Grip L, Serruys PW, Fitzgerald P, et al. Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial. Circulation. 2002;106:1243–50.CrossRef Holmes Jr DR, Savage M, LaBlanche JM, Grip L, Serruys PW, Fitzgerald P, et al. Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial. Circulation. 2002;106:1243–50.CrossRef
28.
Zurück zum Zitat Sheiban I, Villata G, Bollati M, Sillano D, Lotrionte M, Biondi-Zoccai G. Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V®). Vasc Health Risk Manag. 2008; 4:31–8.CrossRef Sheiban I, Villata G, Bollati M, Sillano D, Lotrionte M, Biondi-Zoccai G. Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V®). Vasc Health Risk Manag. 2008; 4:31–8.CrossRef
29.
Zurück zum Zitat Sheiban I, Leonardo F, Rosano GM, Pagnotta P, Marsico F, Montorfano M, et al. Predictors of long-term clinical outcome in patients undergoing multiple vessel stenting for coronary artery disease. Ital Heart J. 2000;1:480–6. Sheiban I, Leonardo F, Rosano GM, Pagnotta P, Marsico F, Montorfano M, et al. Predictors of long-term clinical outcome in patients undergoing multiple vessel stenting for coronary artery disease. Ital Heart J. 2000;1:480–6.
30.
Zurück zum Zitat Sheiban I, Albiero R, Marsico F, Dharmadhikari A, Tzifos V, Pagnotta P, et al. Immediate and long-term results of “T” stenting for bifurcation coronary lesions. Am J Cardiol. 2000;85:1141–4.CrossRef Sheiban I, Albiero R, Marsico F, Dharmadhikari A, Tzifos V, Pagnotta P, et al. Immediate and long-term results of “T” stenting for bifurcation coronary lesions. Am J Cardiol. 2000;85:1141–4.CrossRef
31.
Zurück zum Zitat Takebayashi H, Kobayashi Y, Dangas G, Fujii K, Mintz GS, Stone GW, et al. Restenosis due to underexpansion of sirolimus-eluting stent in a bifurcation lesion. Catheter Cardiovasc Interv. 2003;60:496–9.CrossRef Takebayashi H, Kobayashi Y, Dangas G, Fujii K, Mintz GS, Stone GW, et al. Restenosis due to underexpansion of sirolimus-eluting stent in a bifurcation lesion. Catheter Cardiovasc Interv. 2003;60:496–9.CrossRef
32.
Zurück zum Zitat Morice MC, Serruys PW, Sousa JE. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346:1773–80.CrossRef Morice MC, Serruys PW, Sousa JE. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346:1773–80.CrossRef
33.
Zurück zum Zitat Ranade SV, Miller KM, Richard RE, Chan AK, Allen MJ, Helmus MN. Physical characterization of controlled release of paclitaxel from the TAXUS™ Express2™ drug-eluting stent. J Biomed Mater Res A. 2004;71: 625–34.CrossRef Ranade SV, Miller KM, Richard RE, Chan AK, Allen MJ, Helmus MN. Physical characterization of controlled release of paclitaxel from the TAXUS™ Express2™ drug-eluting stent. J Biomed Mater Res A. 2004;71: 625–34.CrossRef
34.
Zurück zum Zitat Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346:1773–80.CrossRef Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346:1773–80.CrossRef
35.
Zurück zum Zitat Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O’Shaughnessy C, et al. SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003; 349:1315–23.CrossRef Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O’Shaughnessy C, et al. SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003; 349:1315–23.CrossRef
36.
Zurück zum Zitat Grube E, Silber S, Hauptmann KE, Mueller R, Buellesfeld L, Gerckens U, et al. TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation. 2003;107:38–42.CrossRef Grube E, Silber S, Hauptmann KE, Mueller R, Buellesfeld L, Gerckens U, et al. TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation. 2003;107:38–42.CrossRef
37.
Zurück zum Zitat Colombo A, Drzewiecki J, Banning A, Grube E, Hauptmann K, Silber S, et al. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation. 2003;108:788–94.CrossRef Colombo A, Drzewiecki J, Banning A, Grube E, Hauptmann K, Silber S, et al. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation. 2003;108:788–94.CrossRef
38.
Zurück zum Zitat Maisel WH. Unanswered questions—drug-eluting stents and the risk of late thrombosis. N Engl J Med. 2007;356:981–4.CrossRef Maisel WH. Unanswered questions—drug-eluting stents and the risk of late thrombosis. N Engl J Med. 2007;356:981–4.CrossRef
39.
Zurück zum Zitat Chitkara K, Pujara K. Drug-eluting stents in acute coronary syndrome: is there a risk of stent thrombosis with second-generation stents? Eur J Cardiovasc Med. 2010;1:20–4. Chitkara K, Pujara K. Drug-eluting stents in acute coronary syndrome: is there a risk of stent thrombosis with second-generation stents? Eur J Cardiovasc Med. 2010;1:20–4.
40.
Zurück zum Zitat Levy Y, Tal N, Tzemach G, Weinberger J, Domb AJ, Mandler D. Drug-eluting stent with improved durability and controllability properties, obtained via electrocoated adhesive promotion layer. J Biomed Mater Res B Appl Biomater. 2009;91:819–30. Levy Y, Tal N, Tzemach G, Weinberger J, Domb AJ, Mandler D. Drug-eluting stent with improved durability and controllability properties, obtained via electrocoated adhesive promotion layer. J Biomed Mater Res B Appl Biomater. 2009;91:819–30.
41.
Zurück zum Zitat Belle EV, Susen S, Jude B, Bertrand ME. Drug eluting stents: trading restenosis for thrombosis. J Thrombosis Haemost. 2007;5:238–45.CrossRef Belle EV, Susen S, Jude B, Bertrand ME. Drug eluting stents: trading restenosis for thrombosis. J Thrombosis Haemost. 2007;5:238–45.CrossRef
42.
Zurück zum Zitat Windecker S, Mierer B. Late coronary late thrombosis. Circulation. 2007; 116:1952–65.CrossRef Windecker S, Mierer B. Late coronary late thrombosis. Circulation. 2007; 116:1952–65.CrossRef
43.
Zurück zum Zitat Austin D, Pell JP, Oldroyd KG. Drug-eluting stents: do the risks really overweigh the benefits? Heart. 2008;94:127–8.CrossRef Austin D, Pell JP, Oldroyd KG. Drug-eluting stents: do the risks really overweigh the benefits? Heart. 2008;94:127–8.CrossRef
44.
Zurück zum Zitat Otsuka Y, Chronos NA, Apkarian RP, Robinson KA. Scanning electron microscopic analysis of defects in polymer coatings of three commercially available stents: comparison of BiodivYsio, Taxus, and Cypher Stents. J Invasive Cardiol. 2007;19:71–6. Otsuka Y, Chronos NA, Apkarian RP, Robinson KA. Scanning electron microscopic analysis of defects in polymer coatings of three commercially available stents: comparison of BiodivYsio, Taxus, and Cypher Stents. J Invasive Cardiol. 2007;19:71–6.
45.
Zurück zum Zitat Tesfamariam B. Local vascular toxicokinetics of stent-based drug delivery. Toxicol Lett. 2007;168:93–102.CrossRef Tesfamariam B. Local vascular toxicokinetics of stent-based drug delivery. Toxicol Lett. 2007;168:93–102.CrossRef
46.
Zurück zum Zitat McFadden E, Stabile E, Regar E, Cheneau E, Ong A, Kinnaird T, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet. 2004;364:1466–7.CrossRef McFadden E, Stabile E, Regar E, Cheneau E, Ong A, Kinnaird T, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet. 2004;364:1466–7.CrossRef
47.
Zurück zum Zitat Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi G, Stankovic G, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005;293:2154–6.CrossRef Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi G, Stankovic G, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005;293:2154–6.CrossRef
48.
Zurück zum Zitat Stone GW, Ellis SG, Cox DA, Hermiller J, O’Shaughnessy C, Mann JT, et al. TAXUS-IV Investigators. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004;350:221–31.CrossRef Stone GW, Ellis SG, Cox DA, Hermiller J, O’Shaughnessy C, Mann JT, et al. TAXUS-IV Investigators. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004;350:221–31.CrossRef
49.
Zurück zum Zitat Rasmussen K, Maeng M, Kaltoft A, Thayssen P, Kelbaek H, Tilsted HH, et al. SORT OUT III study group. Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial. Lancet. 2010;375:1090–9.CrossRef Rasmussen K, Maeng M, Kaltoft A, Thayssen P, Kelbaek H, Tilsted HH, et al. SORT OUT III study group. Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial. Lancet. 2010;375:1090–9.CrossRef
50.
Zurück zum Zitat Abizaid A, Costa Jr JR. New drug-eluting stents: an overview on biodegradable and polymer-free next-generation stent systems. Circ Cardiovasc Interv. 2010;3:384–93.CrossRef Abizaid A, Costa Jr JR. New drug-eluting stents: an overview on biodegradable and polymer-free next-generation stent systems. Circ Cardiovasc Interv. 2010;3:384–93.CrossRef
51.
Zurück zum Zitat Kereiakes DJ, Cox DA, Hermiller JB, Midei MG, Bachinsky WB, Nukta ED, et al. Guidant Multi-Link Vision Stent Registry Investigators. Usefulness of a cobalt chromium coronary stent alloy. Am J Cardiol. 2003;92:463–6.CrossRef Kereiakes DJ, Cox DA, Hermiller JB, Midei MG, Bachinsky WB, Nukta ED, et al. Guidant Multi-Link Vision Stent Registry Investigators. Usefulness of a cobalt chromium coronary stent alloy. Am J Cardiol. 2003;92:463–6.CrossRef
52.
Zurück zum Zitat Pelton AR, Schroeder V, Mitchell MR, Gong XY, Barney M, Robertson SW. Fatigue and durability of Nitinol stents. J Mech Behav Biomed Mater. 2008; 1:153–64.CrossRef Pelton AR, Schroeder V, Mitchell MR, Gong XY, Barney M, Robertson SW. Fatigue and durability of Nitinol stents. J Mech Behav Biomed Mater. 2008; 1:153–64.CrossRef
53.
Zurück zum Zitat Burt HM, Hunter WL. Drug-eluting stents: a multidisciplinary success story. Adv Drug Deliv Rev. 2006;58:350–7.CrossRef Burt HM, Hunter WL. Drug-eluting stents: a multidisciplinary success story. Adv Drug Deliv Rev. 2006;58:350–7.CrossRef
54.
Zurück zum Zitat Kukreja N, Onuma Y, Daemen J, Serruys PW. The future of drug-eluting stents. Pharmacol Res. 2008;57:171–80.CrossRef Kukreja N, Onuma Y, Daemen J, Serruys PW. The future of drug-eluting stents. Pharmacol Res. 2008;57:171–80.CrossRef
55.
Zurück zum Zitat Haïdopoulos M, Turgeon S, Sarra-Bournet C, Laroche G, Mantovani D. Development of an optimized electrochemical process for subsequent coating of 316 stainless steel for stent applications. J Mater Sci Mater Med. 2006; 17:647–57.CrossRef Haïdopoulos M, Turgeon S, Sarra-Bournet C, Laroche G, Mantovani D. Development of an optimized electrochemical process for subsequent coating of 316 stainless steel for stent applications. J Mater Sci Mater Med. 2006; 17:647–57.CrossRef
56.
Zurück zum Zitat Adams RO. A review of the stainless steel surface. J Vasc Sci Technol A. 1983;1:12–8.CrossRef Adams RO. A review of the stainless steel surface. J Vasc Sci Technol A. 1983;1:12–8.CrossRef
57.
Zurück zum Zitat Istephanous N, Bai Z, Gilbert JL, Rohly K, Belu A, Trausch I, et al. Oxide films on metallic biomaterials: myths, facts and opportunities. Materials Sci Forum. 2003;426–4:3157–63.CrossRef Istephanous N, Bai Z, Gilbert JL, Rohly K, Belu A, Trausch I, et al. Oxide films on metallic biomaterials: myths, facts and opportunities. Materials Sci Forum. 2003;426–4:3157–63.CrossRef
58.
Zurück zum Zitat Köster R, Vieluf D, Kiehn M, Sommerauer M, Kähler J, Baldus S, et al. Nickel and molybdenum contact allergies in patients with coronary in-stent restenosis. Lancet. 2000;356:1895–7.CrossRef Köster R, Vieluf D, Kiehn M, Sommerauer M, Kähler J, Baldus S, et al. Nickel and molybdenum contact allergies in patients with coronary in-stent restenosis. Lancet. 2000;356:1895–7.CrossRef
59.
Zurück zum Zitat Lee YK, Hyung Park J, Tae Moon H, Yun Lee D, Han Yun J, Byun Y. The short-term effects on restenosis and thrombosis of echinomycin-eluting stents topcoated with a hydrophobic heparin-containing polymer. Biomaterials. 2007;28:1523–30.CrossRef Lee YK, Hyung Park J, Tae Moon H, Yun Lee D, Han Yun J, Byun Y. The short-term effects on restenosis and thrombosis of echinomycin-eluting stents topcoated with a hydrophobic heparin-containing polymer. Biomaterials. 2007;28:1523–30.CrossRef
60.
Zurück zum Zitat Lewis AL, Vick TA, Collias AC, Hughes LG, Palmer RR, Leppard SW, et al. Phosphorylcholine-based polymer coatings for stent drug delivery. J Mater Sci Mater Med. 2001;12:865–70.CrossRef Lewis AL, Vick TA, Collias AC, Hughes LG, Palmer RR, Leppard SW, et al. Phosphorylcholine-based polymer coatings for stent drug delivery. J Mater Sci Mater Med. 2001;12:865–70.CrossRef
61.
Zurück zum Zitat Lewis AL, Willis SL, Small SA, Hunt SR, O’byrne V, Stratford PW. Drug loading and elution from a phosphorylcholine polymer-coated coronary stent does not affect long-term stability of the coating in vivo. Biomed Mater Eng. 2004;14:355–70. Lewis AL, Willis SL, Small SA, Hunt SR, O’byrne V, Stratford PW. Drug loading and elution from a phosphorylcholine polymer-coated coronary stent does not affect long-term stability of the coating in vivo. Biomed Mater Eng. 2004;14:355–70.
62.
Zurück zum Zitat Acharya G, Park K. Mechanisms of controlled drug release from drug-eluting stents. Adv Drug Deliv Rev. 2006;58:387–401.CrossRef Acharya G, Park K. Mechanisms of controlled drug release from drug-eluting stents. Adv Drug Deliv Rev. 2006;58:387–401.CrossRef
63.
Zurück zum Zitat Basalus MW, Ankone MJ, van Houwelingen GK, de Man FH, von Birgelen C. Coating irregularities of durable polymer-based drug-eluting stents as assessed by scanning electron microscopy. EuroIntervention. 2009;5:157–65.CrossRef Basalus MW, Ankone MJ, van Houwelingen GK, de Man FH, von Birgelen C. Coating irregularities of durable polymer-based drug-eluting stents as assessed by scanning electron microscopy. EuroIntervention. 2009;5:157–65.CrossRef
64.
Zurück zum Zitat Okner R, Oron M, Tal N, Nyska A, Kumar N, Mandler D, et al. Electrocoating of stainless steel coronary stents for extended release of paclitaxel. J Biomed Mater Res A. 2009;88:427–36. Okner R, Oron M, Tal N, Nyska A, Kumar N, Mandler D, et al. Electrocoating of stainless steel coronary stents for extended release of paclitaxel. J Biomed Mater Res A. 2009;88:427–36.
65.
Zurück zum Zitat Lahann J, Klee D, Thelen H, Bienert H, Vorwerk D, Hoecker H. Improvement of haemocompatibility of metallic stents by polymer coating. J Mater Sci Mater Med. 1999;10:443–8.CrossRef Lahann J, Klee D, Thelen H, Bienert H, Vorwerk D, Hoecker H. Improvement of haemocompatibility of metallic stents by polymer coating. J Mater Sci Mater Med. 1999;10:443–8.CrossRef
66.
Zurück zum Zitat Wiemer M, Butz T, Schmidt W, Schmitz KP, Horstkotte D, Langer C. Scanning electron microscopic analysis of different drug eluting stents after failed implantation: from nearly undamaged to major damaged polymers. Catheter Cardiovasc Interv. 2010;75:905–11. Wiemer M, Butz T, Schmidt W, Schmitz KP, Horstkotte D, Langer C. Scanning electron microscopic analysis of different drug eluting stents after failed implantation: from nearly undamaged to major damaged polymers. Catheter Cardiovasc Interv. 2010;75:905–11.
67.
Zurück zum Zitat Westedt U, Wittmar M, Hellwig M, Hanefeld P, Greiner A, Schaper AK, et al. Paclitaxel releasing films consisting of poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) and their potential as biodegradable stent coatings. J Controlled Release. 2006;111:235–46.CrossRef Westedt U, Wittmar M, Hellwig M, Hanefeld P, Greiner A, Schaper AK, et al. Paclitaxel releasing films consisting of poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) and their potential as biodegradable stent coatings. J Controlled Release. 2006;111:235–46.CrossRef
68.
Zurück zum Zitat Konno T, Watanabe J, Ishihara K. Enhanced solubility of paclitaxel using water-soluble and biocompatible 2-methacryloyloxyethyl phosphorylcholine polymers. J Biomed Mater Res A. 2003;65:210–5. Konno T, Watanabe J, Ishihara K. Enhanced solubility of paclitaxel using water-soluble and biocompatible 2-methacryloyloxyethyl phosphorylcholine polymers. J Biomed Mater Res A. 2003;65:210–5.
69.
Zurück zum Zitat Okner R, Shaulov Y, Tal N, Favaro G, Domb AJ, Mandler D. Electropolymerized tricopolymer based on N-pyrrole derivatives as a primer coating for improving the performance of a drug-eluting stent. ACS Appl Mater Interfaces. 2009;1:758–67.CrossRef Okner R, Shaulov Y, Tal N, Favaro G, Domb AJ, Mandler D. Electropolymerized tricopolymer based on N-pyrrole derivatives as a primer coating for improving the performance of a drug-eluting stent. ACS Appl Mater Interfaces. 2009;1:758–67.CrossRef
70.
Zurück zum Zitat Okner R, Domb AJ, Mandler D. Electrochemical formation and characterization of copolymers based on N-pyrrole derivatives. Biomacromolecules. 2007;8:2928–35.CrossRef Okner R, Domb AJ, Mandler D. Electrochemical formation and characterization of copolymers based on N-pyrrole derivatives. Biomacromolecules. 2007;8:2928–35.CrossRef
71.
Zurück zum Zitat Shaulov Y, Okner R, Levi Y, Tal N, Gutkin V, Mandler D, et al. Poly(methyl methacrylate) grafting onto stainless steel surfaces: application to drug-eluting stents. ACS Appl Mater Interfaces. 2009;1:2519–28.CrossRef Shaulov Y, Okner R, Levi Y, Tal N, Gutkin V, Mandler D, et al. Poly(methyl methacrylate) grafting onto stainless steel surfaces: application to drug-eluting stents. ACS Appl Mater Interfaces. 2009;1:2519–28.CrossRef
72.
Zurück zum Zitat Verenitskaya TV, Efimov ON. Polypyrrole: a conducting polymer; its synthesis, properties and applications. Russ Chem Rev. 1997;66:443–57.CrossRef Verenitskaya TV, Efimov ON. Polypyrrole: a conducting polymer; its synthesis, properties and applications. Russ Chem Rev. 1997;66:443–57.CrossRef
73.
Zurück zum Zitat Zhang Z, Roy R, Dugré FJ, Tessier D, Dao LH. In vitro biocompatibility study of electrically conductive polypyrrole-coated polyester fabrics. J Biomed Mater Res. 2001;57:63–71.CrossRef Zhang Z, Roy R, Dugré FJ, Tessier D, Dao LH. In vitro biocompatibility study of electrically conductive polypyrrole-coated polyester fabrics. J Biomed Mater Res. 2001;57:63–71.CrossRef
74.
Zurück zum Zitat Wang X, Gu X, Yuan C, Chen S, Zhang P, Zhang T, et al. Evaluation of biocompatibility of polypyrrole in vitro and in vivo. J Biomed Mater Res A. 2004;68:411–22.CrossRef Wang X, Gu X, Yuan C, Chen S, Zhang P, Zhang T, et al. Evaluation of biocompatibility of polypyrrole in vitro and in vivo. J Biomed Mater Res A. 2004;68:411–22.CrossRef
75.
Zurück zum Zitat Levy Y, Mandler D, Weinberger J, Domb AJ. Evaluation of drug-eluting stents’ coating durability–clinical and regulatory implications. J Biomed Mater Res B Appl Biomater. 2009;91:441–51. Levy Y, Mandler D, Weinberger J, Domb AJ. Evaluation of drug-eluting stents’ coating durability–clinical and regulatory implications. J Biomed Mater Res B Appl Biomater. 2009;91:441–51.
76.
Zurück zum Zitat Mahapatro A, Johnson DM, Patel DN, Feldman MD, Ayon AA, Agrawal CM. Surface modification of functional self-assembled monolayers on 316L stainless steel via lipase catalysis. Langmuir. 2006;22:901–5.CrossRef Mahapatro A, Johnson DM, Patel DN, Feldman MD, Ayon AA, Agrawal CM. Surface modification of functional self-assembled monolayers on 316L stainless steel via lipase catalysis. Langmuir. 2006;22:901–5.CrossRef
77.
Zurück zum Zitat Mahapatro A, Johnson D, Patel D, Feldman M, Ayon A, Agrawal C. Drug delivery from therapeutic self-assembled monolayers (T-SAMs) on 316L stainless steel. Curr Top Med Chem. 2008;8:281–9.CrossRef Mahapatro A, Johnson D, Patel D, Feldman M, Ayon A, Agrawal C. Drug delivery from therapeutic self-assembled monolayers (T-SAMs) on 316L stainless steel. Curr Top Med Chem. 2008;8:281–9.CrossRef
78.
Zurück zum Zitat Mani G, Johnson DM, Marton D, Feldman MD, Patel D, Ayon AA, et al. Drug delivery from gold and titanium surfaces using self-assembled monolayers. Biomaterials. 2008;29:4561–73.CrossRef Mani G, Johnson DM, Marton D, Feldman MD, Patel D, Ayon AA, et al. Drug delivery from gold and titanium surfaces using self-assembled monolayers. Biomaterials. 2008;29:4561–73.CrossRef
79.
Zurück zum Zitat Ulman A. Formation and structure of self-assembled monolayers. Chem Rev. 1996;96:1533–54.CrossRef Ulman A. Formation and structure of self-assembled monolayers. Chem Rev. 1996;96:1533–54.CrossRef
80.
Zurück zum Zitat Shustak G, Domb AJ, Mandler D. Preparation and characterization of n-alkanoic acid self-assembled monolayers adsorbed on 316L stainless steel. Langmuir. 2004;20:7499–506.CrossRef Shustak G, Domb AJ, Mandler D. Preparation and characterization of n-alkanoic acid self-assembled monolayers adsorbed on 316L stainless steel. Langmuir. 2004;20:7499–506.CrossRef
81.
Zurück zum Zitat Volmer-Uebing M, Stratmann M. A surface analytical and an electrochemical study of iron surfaces modified by thiols. Appl Surface Sci. 1992;55:19–35.CrossRef Volmer-Uebing M, Stratmann M. A surface analytical and an electrochemical study of iron surfaces modified by thiols. Appl Surface Sci. 1992;55:19–35.CrossRef
82.
Zurück zum Zitat Ruan CM, Bayer T, Meth S, Sukenik CN. Creation and characterization of n-alkylthiol and n-alkylamine self-assembled monolayers on 316L stainless steel. Thin Solid Films. 2002;419:95–104.CrossRef Ruan CM, Bayer T, Meth S, Sukenik CN. Creation and characterization of n-alkylthiol and n-alkylamine self-assembled monolayers on 316L stainless steel. Thin Solid Films. 2002;419:95–104.CrossRef
83.
Zurück zum Zitat Reinartz C, Fuerbeth W, Stratmann M. Adsorption and characterization of molecular adhesion promoter monolayers on iron surfaces under UHV conditions. Fresenius J Anal Chem. 1995;353:657–60.CrossRef Reinartz C, Fuerbeth W, Stratmann M. Adsorption and characterization of molecular adhesion promoter monolayers on iron surfaces under UHV conditions. Fresenius J Anal Chem. 1995;353:657–60.CrossRef
84.
Zurück zum Zitat Stratmann M. Chemically modified metal surfaces—a new class of composite materials. Adv Mater. 1990;2:191–5.CrossRef Stratmann M. Chemically modified metal surfaces—a new class of composite materials. Adv Mater. 1990;2:191–5.CrossRef
85.
Zurück zum Zitat Bascom WD. Structure of silane adhesion promoter films on glass and metal surfaces. Macromolecules. 1972;5:792–8.CrossRef Bascom WD. Structure of silane adhesion promoter films on glass and metal surfaces. Macromolecules. 1972;5:792–8.CrossRef
86.
Zurück zum Zitat Sathyanarayana MN, Yaseen M. Role of promoters in improving adhesion of organic coatings to a substrate. Prog Org Coat. 1995;26:275–313.CrossRef Sathyanarayana MN, Yaseen M. Role of promoters in improving adhesion of organic coatings to a substrate. Prog Org Coat. 1995;26:275–313.CrossRef
87.
Zurück zum Zitat Shustak G, Domb AJ, Mandler D. n-Alkanoic acid monolayers on 316L stainless steel promote the adhesion of electropolymerized polypyrrole films. Langmuir. 2006;22:5237–40.CrossRef Shustak G, Domb AJ, Mandler D. n-Alkanoic acid monolayers on 316L stainless steel promote the adhesion of electropolymerized polypyrrole films. Langmuir. 2006;22:5237–40.CrossRef
88.
Zurück zum Zitat Okner R, Favaro G, Radko A, Domb AJ, Mandler D. Electrochemical codeposition of sol–gel films on stainless steel: controlling the chemical and physical coating properties of biomedical implants. Phys Chem Chem Phys. 2010;12:15265–73.CrossRef Okner R, Favaro G, Radko A, Domb AJ, Mandler D. Electrochemical codeposition of sol–gel films on stainless steel: controlling the chemical and physical coating properties of biomedical implants. Phys Chem Chem Phys. 2010;12:15265–73.CrossRef
Metadaten
Titel
Intracoronary Stents: Medical Devices at the Interface of Biology and Electrochemistry
verfasst von
Michael B. Boffa
Marlys L. Koschinsky
Copyright-Jahr
2013
Verlag
Springer US
DOI
https://doi.org/10.1007/978-1-4614-6148-7_3